Skip to main content

biovu Archives

Landmark academic-industry partnership harvests human genome “fruits” for research

Nov. 14, 2023—The first fruits of a landmark academic-industry partnership that is harvesting the depth and breadth of the human genome to better understand and treat disease will become available to researchers in the spring of 2024.

Read more


Polygenic “scores” may improve cancer screening

Oct. 31, 2023—Accounting for genetic variability in biomarkers not associated with cancer risk could avoid unnecessary diagnostic procedures, Vanderbilt researchers found.

Read more


New “DNA” podcast season explores how to harness change, ideas to improve business and medicine

Oct. 2, 2023—Go to your favorite podcast channel right now to subscribe and listen to the first episode of Season 4!

Read more


What could be next? Preview DNA’s Season 4 exploring the future

Sep. 25, 2023—Preview the trailer for Season 4 of the Vanderbilt Health DNA podcast series. Explore issues facing businesses across industries, and how VUMC is experimenting with and designing solutions for problems — old and new — by supporting smart people with visionary ideas. 

Read more


New reference tool supports replication of DNA biobank studies

Aug. 31, 2023—Vanderbilt researchers created a phenotype-genotype reference map to assess data quality in DNA biobanks.

Read more


The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Jul. 18, 2023—Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.

Read more


Alliance for Genomic Discovery FAQs

Jul. 18, 2023—Here are frequently asked questions about Vanderbilt University Medical Center's Alliance for Genomic Discovery.

Read more


Billing codes aid lupus diagnosis

May. 18, 2023—Vanderbilt researchers used billing codes in electronic health records to develop a “phenotype risk score” that identified established and undiagnosed people with lupus.

Read more


Anti-nausea drug response in children

Jan. 10, 2023—Genetic variation in a metabolic enzyme was not associated with response to the anti-nausea drug odansetron in children, Vanderbilt researchers report.

Read more


Nashville Biosciences and Illumina announce sequencing agreement with Amgen

Jan. 9, 2023—Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.

Read more


Vanderbilt University Medical Center’s BioVU reaches milestone with biological samples

Dec. 19, 2022—BioVU, Vanderbilt University Medical Center’s biobank, has reached another milestone — deep-freeze storage of more than 300,000 biological samples.

Read more


New high-tech biobank safeguards critical specimens

Aug. 25, 2022—by Bill Snyder Vanderbilt University Medical Center has opened a state-of-the-art automated biobanking system that can store as many as 10 million biospecimens, including blood and body fluids, tissue, and genetic and protein material, at temperatures down to minus 80 degrees Celsius. The “BioStore” was purchased from its manufacturer, Massachusetts-based Azenta Life Sciences, with the...

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more